Treffer 1 - 5 von 5 für Suche 'Dahan, Franck Benjamin', Suchdauer: 0,40s Treffer weiter einschränken
  1. 1
    Systems and methods for managing power

    Systems and methods for managing power von Mair, Hugh Thomas, Song, James Sangwon, Dahan, Franck Benjamin, Wilson, William Douglas, Culp, Norman LeRoy, Thiruvengadam, Sudha

    Volltext bestellen
    Patent

    Zu den Favoriten
    Gespeichert in:
  2. 2
    Systems and methods for managing power

    Systems and methods for managing power von DAHAN FRANCK BENJAMIN, WILSON WILLIAM DOUGLAS, MAIR HUGH THOMAS, CULP NORMAN LEROY, THIRUVENGADAM SUDHA, SONG JAMES SANGWON

    Volltext bestellen
    Patent

    Zu den Favoriten
    Gespeichert in:
  3. 3
    Systems and methods for managing power

    Systems and methods for managing power von DAHAN FRANCK BENJAMIN, WILSON WILLIAM DOUGLAS, MAIR HUGH THOMAS, CULP NORMAN LEROY, THIRUVENGADAM SUDHA, SONG JAMES SANGWON

    Volltext bestellen
    Patent

    Zu den Favoriten
    Gespeichert in:
  4. 4
    Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients

    Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients von Ebbo, Mikael, Grados, Aurélie, Samson, Maxime, Groh, Matthieu, Loundou, Anderson, Rigolet, Aude, Terrier, Benjamin, Guillaud, Constance, Carra-Dallière, Clarisse, Renou, Frédéric, Pozdzik, Agnieszka, Labauge, Pierre, Palat, Sylvain, Berthelot, Jean-Marie, Pennaforte, Jean-Loup, Wynckel, Alain, Lebas, Céline, Le Gouellec, Noémie, Quémeneur, Thomas, Dahan, Karine, Carbonnel, Franck, Leroux, Gaëlle, Perlat, Antoinette, Mathian, Alexis, Cacoub, Patrice, Hachulla, Eric, Costedoat-Chalumeau, Nathalie, Harlé, Jean-Robert, Schleinitz, Nicolas

    Veröffentlicht in PloS one

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  5. 5
    Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients

    Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients von Ebbo, Mikael, Grados, Aurélie, Samson, Maxime, Groh, Matthieu, Loundou, Anderson, Rigolet, Aude, Terrier, Benjamin, Guillaud, Constance, Carra-Dallière, Clarisse, Renou, Frédéric, Pozdzik, Agnieszka, Labauge, Pierre, Palat, Sylvain, Berthelot, Jean-Marie, Pennaforte, Jean-Loup, Wynckel, Alain, Lebas, Céline, Le Gouellec, Noémie, Quémeneur, Thomas, Dahan, Karine, Carbonnel, Franck, Leroux, Gaëlle, Perlat, Antoinette, Mathian, Alexis, Cacoub, Patrice, Hachulla, Eric, Costedoat-Chalumeau, Nathalie, Harlé, Jean-Robert, Schleinitz, Nicolas

    Veröffentlicht in PloS one

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: